Correlation between Serum Levels of Protein-Bound Uremic Toxins in Hemodialysis Patients Measured by LC/MS/MS|
Wednesday, January 15, 2014
Mass spectrometry has been successfully applied for the identification and quantification of uremic toxins.
Stemina Awarded $10 Million EPA Contract
Monday, January 13, 2014
Company announces awarded a contract by the United States Environmental Protection Agency under the EPA’s ToxCast initiative.
Lipidomic Mass Spectrometry and its Application in Neuroscience
Thursday, January 09, 2014
This review presents an overview of MS techniques that enable the identification and relative quantitation of cellular lipidome with a brief discussion on their utility for neuroscience related research.
SRI Establishes Metabolite Standards Synthesis Center for NHLBI
Tuesday, January 07, 2014
Company receives $4.5 million contract from the NHLBI to establish a Metabolite Standards Synthesis Center to prepare molecules for researchers to use in the field of metabolomics.
Metabolon Closes $15 Million Series E Financing
Monday, January 06, 2014
Company raises $15 million through the issuance of preferred stock.
Innovative Screening Strategy Swiftly Uncovers New Drug Candidates, New Biology
Tuesday, December 24, 2013
Method has been utilised to identify compound with promise for obesity-linked diabetes.
AstraZeneca to Acquire Bristol-Myers Squibb Share of Global Diabetes Alliance Assets
Monday, December 23, 2013
Global agreement strengthens AstraZeneca’s commitment to diabetes.
Research Point to Enzyme that Restores Function in Diabetic Kidney Disease
Saturday, December 14, 2013
Data on recent kidney metabolomics findings discussed at the American Society of Nephrology Kidney Week Meeting.
ClinMet Metabolomics Platform Offers Unique Insights into Diabetic Kidney Disease
Friday, December 13, 2013
Findings overturn previous belief regarding relationship of mitochondrial activity and diabetic complications.